BOSTON, MA, Leading prescription digital medicine company developing novel treatments for cognitive dysfunction, today announced that it has successfully closed a $55 million Series C. Read More
PITTSBURGH, PA, Biotechnology company developing innovative technology for organ regeneration, announced today that they have raised $3 million in Series A financing. Read More